company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1871000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4574000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6445000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6445000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,753000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,750000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5695000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5695000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5695000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5695000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63300000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63300000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66142000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:13:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1881000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5224000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7105000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7105000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7104000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7104000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7104000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7104000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71000000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71000000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72045000.0
Corcept Therapeutics Inc,CORT,,0001088856,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:17:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2174000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4924000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7098000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7098000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7101000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7101000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7101000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7101000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,78900000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,78900000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,80764000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:11:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2666000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6203000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8869000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8869000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8882000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8882000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8882000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8882000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,80700000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,80700000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84010000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:13:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3209000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3228000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6437000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6437000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6435000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6435000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6435000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6435000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,80400000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,80400000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84188000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 17:15:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3282000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6646000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9928000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9928000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,17000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9936000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9936000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9936000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9936000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,83000000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,83000000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83309000.0
Corcept Therapeutics Inc,CORT,,0001088856,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7487000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3542000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11029000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11029000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11034000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11034000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11034000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11034000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,84900000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,84900000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84420000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:35:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,875000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,875000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,48000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,48000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,827000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5751000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2668000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8419000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7592000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7597000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7597000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7597000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7597000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,84400000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,84400000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,88621000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 19:28:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1055000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1055000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1031000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5694000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3008000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8702000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7671000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,622000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-622000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8293000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8293000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8293000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8293000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103700000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103700000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99082000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:06:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1377000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1377000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1358000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6482000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4856000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11338000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9980000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1144000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1144000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11124000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11124000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11124000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11124000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,92800000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,92800000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,93015000.0
Corcept Therapeutics Inc,CORT,,0001088856,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1717000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1717000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1697000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8383000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4257000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12640000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10943000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1141000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1141000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12084000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12084000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12084000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12084000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100700000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100700000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99814000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 16:35:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1891000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1891000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1868000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8160000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4491000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12651000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10783000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1114000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1114000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11897000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11897000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11897000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11897000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99100000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99100000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99814000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 19:28:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2634000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2634000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,40000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,40000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2594000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7179000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5155000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12334000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9740000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1166000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1166000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10906000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10906000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10906000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10906000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99100000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99100000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99814000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 16:06:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4115000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4115000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,60000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,60000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4055000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7518000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6567000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14085000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10030000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1094000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1094000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11124000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11124000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11124000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11124000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100000000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100000000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99819000.0
Corcept Therapeutics Inc,CORT,,0001088856,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4405000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4405000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,174000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,174000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4231000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9805000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7285000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17090000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12859000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1071000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1071000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13930000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13930000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13930000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13930000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99500000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99500000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100521000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:39:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5851000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5851000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,215000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,215000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5636000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7965000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4252000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12217000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6581000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,971000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-971000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7552000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7552000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7552000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7552000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,107900000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107900000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100980000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:57:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7282000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7282000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,235000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,235000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7047000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9103000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3047000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12150000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5103000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,903000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-903000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6006000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6006000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6006000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6006000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100100000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100100000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101134000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:46:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9013000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9013000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,258000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,258000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8755000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8043000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3788000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11831000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3076000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,819000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-819000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3895000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3895000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3895000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3895000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100978000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100978000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101200000.0
Corcept Therapeutics Inc,CORT,,0001088856,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10102000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10102000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,302000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,302000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9800000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9453000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4377000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13830000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4030000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,800000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-800000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4830000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4830000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4830000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4830000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,96600000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,96600000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101905000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 13:51:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11956000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11956000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,439000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,439000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11517000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9342000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3341000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12683000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1166000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,770000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-770000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1936000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1936000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1936000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1936000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,107874000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107874000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,96800000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 18:34:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13261000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13261000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,256000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,256000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13005000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9291000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3612000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12903000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,102000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,703000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-703000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-601000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-601000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-601000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-601000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,108461000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,108461000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60100000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 18:18:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14967000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14967000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,364000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,364000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14603000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8863000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4089000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12952000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1651000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2273000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2965000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-692000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,959000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,959000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,959000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,959000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106883000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,106883000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,106800000.0
Corcept Therapeutics Inc,CORT,,0001088856,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16061000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16061000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,403000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,403000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15658000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10432000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4634000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15066000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,592000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,611000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-611000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,109661000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,109661000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 16:46:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19724000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19724000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,426000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,426000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19298000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12118000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5672000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17790000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1508000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,531000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-531000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,977000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,977000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,977000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,977000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,110034000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115329000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,97700000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 18:01:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21725000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21725000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,668000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,668000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21057000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10931000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7054000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17985000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3072000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-487000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-487000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2585000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2585000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2585000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2585000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,110652000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116419000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,129300000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 18:01:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23811000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23811000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,561000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,561000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23250000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11759000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6484000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18243000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5007000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-1142000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1552000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-410000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4597000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4597000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4597000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4597000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,110566000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116139000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,116300000.0
Corcept Therapeutics Inc,CORT,,0001088856,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27599000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27599000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,646000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,646000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26953000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15037000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7176000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22213000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4740000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-225000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-225000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4515000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,127000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4388000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4388000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4388000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112867000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,121189000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109700000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:01:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35559000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35559000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,775000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,775000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34784000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14113000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7876000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21989000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12795000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-98000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-98000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12697000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,50000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12647000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12647000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12647000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113249000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,123011000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115000000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42763000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42763000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,976000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,976000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41787000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16471000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11693000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28164000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13623000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,86000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,86000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13709000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-48000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13757000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13757000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13757000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113603000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,125651000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114600000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:01:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53280000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53280000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1157000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1157000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,52123000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16795000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13631000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30426000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21697000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,188000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,188000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21885000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-76445000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,98330000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,98330000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,98330000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113527000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.87
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,124515000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.79
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113300000.0
Corcept Therapeutics Inc,CORT,,0001088856,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.87
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57659000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57659000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1174000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1174000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,56485000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18440000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17050000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35490000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20995000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,294000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,294000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21289000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3830000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17459000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17459000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17459000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114882000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,127733000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.14
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,116400000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:13:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,62312000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,62312000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1154000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1154000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,61158000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19981000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20543000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40524000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20634000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,562000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,562000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21196000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3000000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18196000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18196000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18196000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115492000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,127515000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.14
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113700000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 17:21:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,64445000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,64445000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1308000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1308000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,63137000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21308000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18860000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40168000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,22969000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,759000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,759000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,23728000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5981000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17747000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17747000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17747000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115798000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,126159000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.14
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,118300000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 17:16:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,66831000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,66831000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1579000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1579000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,65252000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21560000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18794000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40354000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,24898000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1042000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1042000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25940000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3932000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22008000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,22008000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,22008000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115343000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,126688000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,116000000.0
Corcept Therapeutics Inc,CORT,,0001088856,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,64829000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,64829000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1240000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1240000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,63589000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24389000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20244000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44633000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18956000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1097000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1097000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20053000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1779000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18274000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18274000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18274000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114844000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,123895000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114200000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 17:06:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,72257000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,72257000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1377000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1377000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,70880000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24591000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21656000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46247000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,24633000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1178000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1178000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25811000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5600000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20211000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,20186000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,20186000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114340000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,121783000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112100000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 17:21:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,81505000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,81505000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1451000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1451000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,80054000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24245000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22805000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47050000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,33004000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1348000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1348000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,34352000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8012000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26340000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26340000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26340000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113875000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.23
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,121762000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.22
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114500000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 17:16:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,87895000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,87895000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1436000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1436000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,86459000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27134000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24312000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51446000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35013000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1447000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1447000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36460000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7104000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,29356000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,29381000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,29381000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114349000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,122566000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114900000.0
Corcept Therapeutics Inc,CORT,,0001088856,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
